-
1
-
-
84876058856
-
Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome
-
Goldenberg R., Punthakee Z. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Can J Diabetes 2013, 37:S8-S11.
-
(2013)
Can J Diabetes
, vol.37
, pp. S8-S11
-
-
Goldenberg, R.1
Punthakee, Z.2
-
3
-
-
80053397336
-
Epidemiology of the metabolic syndrome in the USA
-
McCullough A.J. Epidemiology of the metabolic syndrome in the USA. J Dig Dis 2011, 12:333-340.
-
(2011)
J Dig Dis
, vol.12
, pp. 333-340
-
-
McCullough, A.J.1
-
4
-
-
33749536035
-
Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins
-
Tenenbaum A., Fisman E.Z., Motro M., Adler Y. Atherogenic dyslipidemia in metabolic syndrome and type 2 diabetes: therapeutic options beyond statins. Cardiovasc Diabetol 2006, 5:20.
-
(2006)
Cardiovasc Diabetol
, vol.5
, pp. 20
-
-
Tenenbaum, A.1
Fisman, E.Z.2
Motro, M.3
Adler, Y.4
-
5
-
-
34447257373
-
Metabolic syndrome and small dense LDL-cholesterol
-
Hirano T. Metabolic syndrome and small dense LDL-cholesterol. Rinsho Byori - Jpn J Clin Pathol 2007, 55:434-438.
-
(2007)
Rinsho Byori - Jpn J Clin Pathol
, vol.55
, pp. 434-438
-
-
Hirano, T.1
-
6
-
-
0042512336
-
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice
-
De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003, 24:1601-1610.
-
(2003)
Eur Heart J
, vol.24
, pp. 1601-1610
-
-
De Backer, G.1
Ambrosioni, E.2
Borch-Johnsen, K.3
Brotons, C.4
Cifkova, R.5
Dallongeville, J.6
-
7
-
-
34247869031
-
Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum
-
Ascaso J., Gonzalez Santos P., Hernandez Mijares A., Mangas Rojas A., Masana L., Millan J., et al. Management of dyslipidemia in the metabolic syndrome: recommendations of the Spanish HDL-Forum. Am J Cardiovasc Drugs 2007, 7:39-58.
-
(2007)
Am J Cardiovasc Drugs
, vol.7
, pp. 39-58
-
-
Ascaso, J.1
Gonzalez Santos, P.2
Hernandez Mijares, A.3
Mangas Rojas, A.4
Masana, L.5
Millan, J.6
-
8
-
-
84890495215
-
Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis
-
Choi H.D., Shin W.G. Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis. Curr Med Res Opin 2014, 30:1-10.
-
(2014)
Curr Med Res Opin
, vol.30
, pp. 1-10
-
-
Choi, H.D.1
Shin, W.G.2
-
9
-
-
84905746950
-
Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: tale of a roller-coaster
-
Sahebkar A., Watts G.F. Role of selective peroxisome proliferator-activated receptor modulators in managing cardiometabolic disease: tale of a roller-coaster. Diabetes Obes Metab 2014, 10.1111/dom.12277.
-
(2014)
Diabetes Obes Metab
-
-
Sahebkar, A.1
Watts, G.F.2
-
10
-
-
84893649359
-
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease
-
Sahebkar A., Chew G.T., Watts G.F. New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease. Expert Opin Pharmacother 2014, 15:493-503.
-
(2014)
Expert Opin Pharmacother
, vol.15
, pp. 493-503
-
-
Sahebkar, A.1
Chew, G.T.2
Watts, G.F.3
-
11
-
-
84882927131
-
New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes
-
Sahebkar A., Watts G.F. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther 2013, 35:1082-1098.
-
(2013)
Clin Ther
, vol.35
, pp. 1082-1098
-
-
Sahebkar, A.1
Watts, G.F.2
-
12
-
-
84892369781
-
New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?
-
Sahebkar A., Watts G.F. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?. Cardiovasc Drugs Ther 2013, 27:559-567.
-
(2013)
Cardiovasc Drugs Ther
, vol.27
, pp. 559-567
-
-
Sahebkar, A.1
Watts, G.F.2
-
13
-
-
79955768525
-
Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease
-
Sahebkar A. Potential efficacy of ginger as a natural supplement for nonalcoholic fatty liver disease. World J Gastroenterol 2011, 17:271-272.
-
(2011)
World J Gastroenterol
, vol.17
, pp. 271-272
-
-
Sahebkar, A.1
-
14
-
-
80052701554
-
Citrus auraptene: a potential multifunctional therapeutic agent for nonalcoholic fatty liver disease
-
Sahebkar A. Citrus auraptene: a potential multifunctional therapeutic agent for nonalcoholic fatty liver disease. Ann Hepatol 2011, 10:575-577.
-
(2011)
Ann Hepatol
, vol.10
, pp. 575-577
-
-
Sahebkar, A.1
-
15
-
-
84857568259
-
Investigation of the effects of Chlorella vulgaris as an adjunctive therapy for dyslipidemia: results of a randomised open-label clinical trial
-
Panahi Y., Pishgoo B., Jalalian H.R., Mohammadi E., Taghipour H.R., Sahebkar A., et al. Investigation of the effects of Chlorella vulgaris as an adjunctive therapy for dyslipidemia: results of a randomised open-label clinical trial. Nutr Diet 2012, 69:13-19.
-
(2012)
Nutr Diet
, vol.69
, pp. 13-19
-
-
Panahi, Y.1
Pishgoo, B.2
Jalalian, H.R.3
Mohammadi, E.4
Taghipour, H.R.5
Sahebkar, A.6
-
16
-
-
84872062209
-
Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial
-
Panahi Y., Ghamarchehreh M.E., Beiraghdar F., Zare M., Jalalian H.R., Sahebkar A. Investigation of the effects of Chlorella vulgaris supplementation in patients with non-alcoholic fatty liver disease: a randomized clinical trial. Hepato-Gastroenterology 2012, 59:2099-2103.
-
(2012)
Hepato-Gastroenterology
, vol.59
, pp. 2099-2103
-
-
Panahi, Y.1
Ghamarchehreh, M.E.2
Beiraghdar, F.3
Zare, M.4
Jalalian, H.R.5
Sahebkar, A.6
-
17
-
-
84871971567
-
Therapeutic roles of curcumin: lessons learned from clinical trials
-
Gupta S.C., Patchva S., Aggarwal B.B. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J 2013, 15:195-218.
-
(2013)
AAPS J
, vol.15
, pp. 195-218
-
-
Gupta, S.C.1
Patchva, S.2
Aggarwal, B.B.3
-
18
-
-
84874110026
-
Curcumin, a component of turmeric: from farm to pharmacy
-
Gupta S.C., Kismali G., Aggarwal B.B. Curcumin, a component of turmeric: from farm to pharmacy. Biofactors 2013, 39:2-13.
-
(2013)
Biofactors
, vol.39
, pp. 2-13
-
-
Gupta, S.C.1
Kismali, G.2
Aggarwal, B.B.3
-
19
-
-
77957204556
-
Molecular mechanisms for curcumin benefits against ischemic injury
-
[author reply e7]
-
Sahebkar A. Molecular mechanisms for curcumin benefits against ischemic injury. Fertil Steril 2010, 94:e75-e76. [author reply e7].
-
(2010)
Fertil Steril
, vol.94
, pp. e75-e76
-
-
Sahebkar, A.1
-
22
-
-
84872467113
-
A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications
-
Panahi Y., Sahebkar A., Parvin S., Saadat A. A randomized controlled trial on the anti-inflammatory effects of curcumin in patients with chronic sulphur mustard-induced cutaneous complications. Ann Clin Biochem 2012, 49:580-588.
-
(2012)
Ann Clin Biochem
, vol.49
, pp. 580-588
-
-
Panahi, Y.1
Sahebkar, A.2
Parvin, S.3
Saadat, A.4
-
23
-
-
84869485341
-
Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial
-
Panahi Y., Sahebkar A., Amiri M., Davoudi S.M., Beiraghdar F., Hoseininejad S.L., et al. Improvement of sulphur mustard-induced chronic pruritus, quality of life and antioxidant status by curcumin: results of a randomised, double-blind, placebo-controlled trial. Br J Nutr 2012, 108:1272-1279.
-
(2012)
Br J Nutr
, vol.108
, pp. 1272-1279
-
-
Panahi, Y.1
Sahebkar, A.2
Amiri, M.3
Davoudi, S.M.4
Beiraghdar, F.5
Hoseininejad, S.L.6
-
24
-
-
38349011007
-
Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials
-
Strimpakos A.S., Sharma R.A. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 2008, 10:511-545.
-
(2008)
Antioxid Redox Signal
, vol.10
, pp. 511-545
-
-
Strimpakos, A.S.1
Sharma, R.A.2
-
25
-
-
84908220474
-
Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial
-
Panahi Y., Rahimnia A.R., Sharafi M., Alishiri G., Saburi A., Sahebkar A. Curcuminoid treatment for knee osteoarthritis: a randomized double-blind placebo-controlled trial. Phytother Res 2014, 10.1002/ptr.5174.
-
(2014)
Phytother Res
-
-
Panahi, Y.1
Rahimnia, A.R.2
Sharafi, M.3
Alishiri, G.4
Saburi, A.5
Sahebkar, A.6
-
26
-
-
75249105458
-
Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo
-
Iranshahi M., Sahebkar A., Hosseini S.T., Takasaki M., Konoshima T., Tokuda H. Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 2010, 17:269-273.
-
(2010)
Phytomedicine
, vol.17
, pp. 269-273
-
-
Iranshahi, M.1
Sahebkar, A.2
Hosseini, S.T.3
Takasaki, M.4
Konoshima, T.5
Tokuda, H.6
-
27
-
-
84908503753
-
Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial
-
Panahi Y., Saadat A., Beiraghdar F., Sahebkar A. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial. Phytother Res 2014, 10.1002/ptr.5149.
-
(2014)
Phytother Res
-
-
Panahi, Y.1
Saadat, A.2
Beiraghdar, F.3
Sahebkar, A.4
-
28
-
-
84895071276
-
Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: a randomized double-blind placebo-controlled trial
-
Panahi Y., Saadat A., Beiraghdar F., Hosseini Nouzari S.M., Jalalian H.R., Sahebkar A. Antioxidant effects of bioavailability-enhanced curcuminoids in patients with solid tumors: a randomized double-blind placebo-controlled trial. J Funct Foods 2014, 6:615-622.
-
(2014)
J Funct Foods
, vol.6
, pp. 615-622
-
-
Panahi, Y.1
Saadat, A.2
Beiraghdar, F.3
Hosseini Nouzari, S.M.4
Jalalian, H.R.5
Sahebkar, A.6
-
29
-
-
84896320682
-
Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial
-
Ganjali S., Sahebkar A., Mahdipour E., Jamialahmadi K., Torabi S., Akhlaghi S., et al. Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial. The Scientific World Journal 2014, art. no. 898361. 10.1155/2014/898361.
-
(2014)
The Scientific World Journal
-
-
Ganjali, S.1
Sahebkar, A.2
Mahdipour, E.3
Jamialahmadi, K.4
Torabi, S.5
Akhlaghi, S.6
-
30
-
-
84900033649
-
Low-density lipoprotein is a potential target for curcumin: novel mechanistic insights
-
Sahebkar A. Low-density lipoprotein is a potential target for curcumin: novel mechanistic insights. Basic Clin Pharmacol Toxicol 2014, 114:437-438.
-
(2014)
Basic Clin Pharmacol Toxicol
, vol.114
, pp. 437-438
-
-
Sahebkar, A.1
-
31
-
-
84930541017
-
Curcumin multiple molecular targets mediate multiple pharmacological actions - a review
-
Shehzad A., Lee Y.S. Curcumin multiple molecular targets mediate multiple pharmacological actions - a review. Drugs Future 2010, 35:113-119.
-
(2010)
Drugs Future
, vol.35
, pp. 113-119
-
-
Shehzad, A.1
Lee, Y.S.2
-
32
-
-
84883399626
-
Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial
-
Na L.X., Li Y., Pan H.Z., Zhou X.L., Sun D.J., Meng M., et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res 2013, 57:1569-1577.
-
(2013)
Mol Nutr Food Res
, vol.57
, pp. 1569-1577
-
-
Na, L.X.1
Li, Y.2
Pan, H.Z.3
Zhou, X.L.4
Sun, D.J.5
Meng, M.6
-
33
-
-
84868150021
-
Curcumin extract for prevention of type 2 diabetes
-
Chuengsamarn S., Rattanamongkolgul S., Luechapudiporn R., Phisalaphong C., Jirawatnotai S. Curcumin extract for prevention of type 2 diabetes. Diabetes Care 2012, 35:2121-2127.
-
(2012)
Diabetes Care
, vol.35
, pp. 2121-2127
-
-
Chuengsamarn, S.1
Rattanamongkolgul, S.2
Luechapudiporn, R.3
Phisalaphong, C.4
Jirawatnotai, S.5
-
34
-
-
84874109481
-
Curcumin and obesity
-
Bradford P.G. Curcumin and obesity. Biofactors 2013, 39:78-87.
-
(2013)
Biofactors
, vol.39
, pp. 78-87
-
-
Bradford, P.G.1
-
35
-
-
80054082262
-
Spice up the hypertension diet - curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension
-
Hlavackova L., Janegova A., Ulicna O., Janega P., Cerna A., Babal P. Spice up the hypertension diet - curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension. Nutr Metab 2011, 8:72.
-
(2011)
Nutr Metab
, vol.8
, pp. 72
-
-
Hlavackova, L.1
Janegova, A.2
Ulicna, O.3
Janega, P.4
Cerna, A.5
Babal, P.6
-
36
-
-
84899477785
-
Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis
-
Sahebkar A. Are curcuminoids effective C-reactive protein-lowering agents in clinical practice? Evidence from a meta-analysis. Phytother Res 2013, 28:633-642.
-
(2013)
Phytother Res
, vol.28
, pp. 633-642
-
-
Sahebkar, A.1
-
37
-
-
45849115079
-
Antioxidant and radical scavenging properties of curcumin
-
Ak T., Gulcin I. Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008, 174:27-37.
-
(2008)
Chem Biol Interact
, vol.174
, pp. 27-37
-
-
Ak, T.1
Gulcin, I.2
-
38
-
-
84890552304
-
Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals
-
Sahebkar A., Mohammadi A., Atabati A., Rahiman S., Tavallaie S., Iranshahi M., et al. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res 2013, 27:1883-1888.
-
(2013)
Phytother Res
, vol.27
, pp. 1883-1888
-
-
Sahebkar, A.1
Mohammadi, A.2
Atabati, A.3
Rahiman, S.4
Tavallaie, S.5
Iranshahi, M.6
-
39
-
-
84874935664
-
Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial
-
Mohammadi A., Sahebkar A., Iranshahi M., Amini M., Khojasteh R., Ghayour-Mobarhan M., et al. Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res 2013, 27:374-379.
-
(2013)
Phytother Res
, vol.27
, pp. 374-379
-
-
Mohammadi, A.1
Sahebkar, A.2
Iranshahi, M.3
Amini, M.4
Khojasteh, R.5
Ghayour-Mobarhan, M.6
-
40
-
-
84870949470
-
Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people
-
DiSilvestro R.A., Joseph E., Zhao S., Bomser J. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle aged people. Nutr J 2012, 11:79.
-
(2012)
Nutr J
, vol.11
, pp. 79
-
-
DiSilvestro, R.A.1
Joseph, E.2
Zhao, S.3
Bomser, J.4
-
41
-
-
84893641080
-
Curcuminoids for the management of hypertriglyceridaemia
-
Sahebkar A. Curcuminoids for the management of hypertriglyceridaemia. Nat Rev Cardiol 2014, 11:123.
-
(2014)
Nat Rev Cardiol
, vol.11
, pp. 123
-
-
Sahebkar, A.1
-
42
-
-
0027080521
-
Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers
-
Soni K.B., Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992, 36:273-275.
-
(1992)
Indian J Physiol Pharmacol
, vol.36
, pp. 273-275
-
-
Soni, K.B.1
Kuttan, R.2
-
43
-
-
84876439194
-
Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
-
Sahebkar A. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?. Biofactors 2013, 39:197-208.
-
(2013)
Biofactors
, vol.39
, pp. 197-208
-
-
Sahebkar, A.1
-
44
-
-
0035897696
-
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J Am Med Assoc 2001, 285:2486-2497.
-
(2001)
J Am Med Assoc
, vol.285
, pp. 2486-2497
-
-
-
45
-
-
0031860081
-
Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers
-
Shoba G., Joy D., Joseph T., Majeed M., Rajendran R., Srinivas P.S. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998, 64:353-356.
-
(1998)
Planta Med
, vol.64
, pp. 353-356
-
-
Shoba, G.1
Joy, D.2
Joseph, T.3
Majeed, M.4
Rajendran, R.5
Srinivas, P.S.6
-
46
-
-
84874113002
-
Molecular mechanisms of hypolipidemic effects of curcumin
-
Zingg J.M., Hasan S.T., Meydani M. Molecular mechanisms of hypolipidemic effects of curcumin. Biofactors 2013, 39:101-121.
-
(2013)
Biofactors
, vol.39
, pp. 101-121
-
-
Zingg, J.M.1
Hasan, S.T.2
Meydani, M.3
-
47
-
-
82955161722
-
Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism
-
Shin S.K., Ha T.Y., McGregor R.A., Choi M.S. Long-term curcumin administration protects against atherosclerosis via hepatic regulation of lipoprotein cholesterol metabolism. Mol Nutr Food Res 2011, 55:1829-1840.
-
(2011)
Mol Nutr Food Res
, vol.55
, pp. 1829-1840
-
-
Shin, S.K.1
Ha, T.Y.2
McGregor, R.A.3
Choi, M.S.4
-
48
-
-
71949103659
-
Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1
-
Kang Q., Chen A. Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1. Endocrinology 2009, 150:5384-5394.
-
(2009)
Endocrinology
, vol.150
, pp. 5384-5394
-
-
Kang, Q.1
Chen, A.2
-
49
-
-
84855503887
-
Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes
-
Shao W., Yu Z., Chiang Y., Yang Y., Chai T., Foltz W., et al. Curcumin prevents high fat diet induced insulin resistance and obesity via attenuating lipogenesis in liver and inflammatory pathway in adipocytes. PLoS ONE 2012, 7:e28784.
-
(2012)
PLoS ONE
, vol.7
, pp. e28784
-
-
Shao, W.1
Yu, Z.2
Chiang, Y.3
Yang, Y.4
Chai, T.5
Foltz, W.6
-
50
-
-
79953694167
-
Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin
-
Zhao J., Sun X.B., Ye F., Tian W.X. Suppression of fatty acid synthase, differentiation and lipid accumulation in adipocytes by curcumin. Mol Cell Biochem 2011, 351:19-28.
-
(2011)
Mol Cell Biochem
, vol.351
, pp. 19-28
-
-
Zhao, J.1
Sun, X.B.2
Ye, F.3
Tian, W.X.4
-
51
-
-
79955008809
-
Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet
-
Kim M., Kim Y. Hypocholesterolemic effects of curcumin via up-regulation of cholesterol 7a-hydroxylase in rats fed a high fat diet. Nutr Res Pract 2010, 4:191-195.
-
(2010)
Nutr Res Pract
, vol.4
, pp. 191-195
-
-
Kim, M.1
Kim, Y.2
-
52
-
-
84855359759
-
Fat digestion and absorption in spice-pretreated rats
-
Prakash U.N., Srinivasan K. Fat digestion and absorption in spice-pretreated rats. J Sci Food Agric 2011, 92:503-510.
-
(2011)
J Sci Food Agric
, vol.92
, pp. 503-510
-
-
Prakash, U.N.1
Srinivasan, K.2
-
53
-
-
36248991885
-
Curcumin effects on blood lipid profile in a 6-month human study
-
Baum L., Cheung S.K., Mok V.C., Lam L.C., Leung V.P., Hui E., et al. Curcumin effects on blood lipid profile in a 6-month human study. Pharmacol Res: Off J Ital Pharmacol Soc 2007, 56:509-514.
-
(2007)
Pharmacol Res: Off J Ital Pharmacol Soc
, vol.56
, pp. 509-514
-
-
Baum, L.1
Cheung, S.K.2
Mok, V.C.3
Lam, L.C.4
Leung, V.P.5
Hui, E.6
-
54
-
-
46349109182
-
Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study
-
Usharani P., Mateen A.A., Naidu M.U., Raju Y.S., Chandra N. Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R&D 2008, 9:243-250.
-
(2008)
Drugs R&D
, vol.9
, pp. 243-250
-
-
Usharani, P.1
Mateen, A.A.2
Naidu, M.U.3
Raju, Y.S.4
Chandra, N.5
-
55
-
-
67651206071
-
The effect of curcumin on lipid level in patients with acute coronary syndrome
-
Alwi I., Santoso T., Suyono S., Sutrisna B., Suyatna F.D., Kresno S.B., et al. The effect of curcumin on lipid level in patients with acute coronary syndrome. Acta Med Indones 2008, 40:201-210.
-
(2008)
Acta Med Indones
, vol.40
, pp. 201-210
-
-
Alwi, I.1
Santoso, T.2
Suyono, S.3
Sutrisna, B.4
Suyatna, F.D.5
Kresno, S.B.6
-
56
-
-
0034693376
-
An hydroalcoholic extract of Curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention
-
Ramirez-Bosca A., Soler A., Carrion M.A., Diaz-Alperi J., Bernd A., Quintanilla C., et al. An hydroalcoholic extract of Curcuma longa lowers the apo B/apo A ratio. Implications for atherogenesis prevention. Mech Ageing Dev 2000, 119:41-47.
-
(2000)
Mech Ageing Dev
, vol.119
, pp. 41-47
-
-
Ramirez-Bosca, A.1
Soler, A.2
Carrion, M.A.3
Diaz-Alperi, J.4
Bernd, A.5
Quintanilla, C.6
-
57
-
-
80054935966
-
Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects
-
Pungcharoenkul K., Thongnopnua P. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytother Res 2011, 25:1721-1726.
-
(2011)
Phytother Res
, vol.25
, pp. 1721-1726
-
-
Pungcharoenkul, K.1
Thongnopnua, P.2
-
58
-
-
84899624901
-
A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels
-
Sahebkar A. A systematic review and meta-analysis of randomized controlled trials investigating the effects of curcumin on blood lipid levels. Clin Nutr 2013, 33:406-414.
-
(2013)
Clin Nutr
, vol.33
, pp. 406-414
-
-
Sahebkar, A.1
-
60
-
-
37549051274
-
Bioavailability of curcumin: problems and promises
-
Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol Pharm 2007, 4:807-818.
-
(2007)
Mol Pharm
, vol.4
, pp. 807-818
-
-
Anand, P.1
Kunnumakkara, A.B.2
Newman, R.A.3
Aggarwal, B.B.4
-
61
-
-
77952379134
-
Tissue distribution and elimination of capsaicin, piperine and curcumin following oral intake in rats
-
Suresh D., Srinivasan K. Tissue distribution and elimination of capsaicin, piperine and curcumin following oral intake in rats. Indian J Med Res 2010, 131:682-691.
-
(2010)
Indian J Med Res
, vol.131
, pp. 682-691
-
-
Suresh, D.1
Srinivasan, K.2
-
62
-
-
62049085133
-
The protective role of curcumin in cardiovascular diseases
-
Wongcharoen W., Phrommintikul A. The protective role of curcumin in cardiovascular diseases. Int J Cardiol 2009, 133:145-151.
-
(2009)
Int J Cardiol
, vol.133
, pp. 145-151
-
-
Wongcharoen, W.1
Phrommintikul, A.2
-
63
-
-
55949117806
-
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
-
Aggarwal B.B., Harikumar K.B. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol 2009, 41:40-59.
-
(2009)
Int J Biochem Cell Biol
, vol.41
, pp. 40-59
-
-
Aggarwal, B.B.1
Harikumar, K.B.2
-
64
-
-
84880702294
-
Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase
-
Um M.Y., Hwang K.H., Ahn J., Ha T.Y. Curcumin attenuates diet-induced hepatic steatosis by activating AMP-activated protein kinase. Basic Clin Pharmacol Toxicol 2013, 113:152-157.
-
(2013)
Basic Clin Pharmacol Toxicol
, vol.113
, pp. 152-157
-
-
Um, M.Y.1
Hwang, K.H.2
Ahn, J.3
Ha, T.Y.4
-
65
-
-
84874118228
-
Curcumin and liver disease
-
Vera-Ramirez L., Perez-Lopez P., Varela-Lopez A., Ramirez-Tortosa M., Battino M., Quiles J.L. Curcumin and liver disease. Biofactors 2013, 39:88-100.
-
(2013)
Biofactors
, vol.39
, pp. 88-100
-
-
Vera-Ramirez, L.1
Perez-Lopez, P.2
Varela-Lopez, A.3
Ramirez-Tortosa, M.4
Battino, M.5
Quiles, J.L.6
-
66
-
-
84891609531
-
Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice
-
Hasan S.T., Zingg J.M., Kwan P., Noble T., Smith D., Meydani M. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis 2014, 232:40-51.
-
(2014)
Atherosclerosis
, vol.232
, pp. 40-51
-
-
Hasan, S.T.1
Zingg, J.M.2
Kwan, P.3
Noble, T.4
Smith, D.5
Meydani, M.6
-
67
-
-
0037382786
-
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome
-
Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
-
(2003)
Hepatology
, vol.37
, pp. 917-923
-
-
Marchesini, G.1
Bugianesi, E.2
Forlani, G.3
Cerrelli, F.4
Lenzi, M.5
Manini, R.6
-
68
-
-
0035174504
-
Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions
-
Cheng A.L., Hsu C.H., Lin J.K., Hsu M.M., Ho Y.F., Shen T.S., et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001, 21:2895-2900.
-
(2001)
Anticancer Res
, vol.21
, pp. 2895-2900
-
-
Cheng, A.L.1
Hsu, C.H.2
Lin, J.K.3
Hsu, M.M.4
Ho, Y.F.5
Shen, T.S.6
|